key: cord-0991061-4zr96aei authors: Callea, Michele; Cammarata‐Scalisi, Francisco; Galeotti, Angela; Villani, Alberto; Valentini, Diletta title: COVID‐19 and Down syndrome date: 2020-06-13 journal: Acta Paediatr DOI: 10.1111/apa.15409 sha: 7ae0e59d0af77ea3edd892a683f449cd5d9ba2ae doc_id: 991061 cord_uid: 4zr96aei The outbreak of severe pneumonia due to the new SARS‐CoV‐2 has created a world emergency that is putting global public health institutions at high alert. Since the first official paper on January 20 up to now more than 10.000 publications have appeared on PubMed. Surprisingly, no single paper has been dealing with the potential impact of the COVID‐19 on Down Syndrome (DS). As COVID‐19 presents as an acute severe respiratory syndrome and DS is by far the most frequent chromosomal disease with the highest susceptibility to develop respiratory infections and complications (1), it seems timely to focus on this syndrome during the ongoing pandemic. The outbreak of severe pneumonia due to the new SARS-CoV-2 has created a world emergency that is putting global public health institutions at high alert. Since the first official paper on January 20 up to now more than 10.000 publications have appeared on PubMed. Surprisingly, no single paper has been dealing with the potential impact of the COVID-19 on Down Syndrome (DS). As COVID-19 presents as an acute severe respiratory syndrome and DS is by far the most frequent chromosomal disease with the highest susceptibility to develop respiratory infections and complications (1) , it seems timely to focus on this syndrome during the ongoing pandemic. DS represents a global problem with more than 5.5 million affected persons, 1:700 cases live births and a 30% increase in the last decades. Likewise the life expectancy is increasing by the years and quite a number of subjects reach the adult life (1). The paediatric age in general seems to be less affected by COVID-19 (2) . However children with DS are especially vulnerable and susceptible to respiratory infections. In addition they have comorbidities such as immunodeficiency, cardiopathies especially those with surgical valve replacement, obesity, diabetes that have been proven to worsen the outcome of COVID-19 patients (3) . Presently there are no official reports on the incidence and evolution of COVID-19 in DS. The Journal Virtual Revista Sindrome de Down has mentioned cases of COVID-19 in patients with DS with a variable evolution, from recovery to death. The Trisomy 21 Research Society is evaluating the evolution of the pandemic in patients with DS in order to answer to two main questions: (i) are subjects with DS more susceptible to COVID-19 infection?; (ii) are they, once infected, at higher risk for complications than the typical population? In the absence of an effective vaccine and of specific antiviral drugs, so far, the COVID-19 treatment remains empiric. Nevertheless progresses have been made by rationalizing the treatment with the combination of drugs to prevent or cure the complications, such as antivirals (remdesevir) antiinflammatory (chloroquine, azythromicin) and anticoagulants (4) . This article is protected by copyright. All rights reserved (http://www.ospedalepediricobambinogesu.it/la-guida-alla-sindrome-di-down-di-a-scuoladi-salute#.XniOidNKhmA). By the appearance of the coronavirus infection in Italy, we have predisposed an ad hoc protocol. This article is protected by copyright. All rights reserved The protocol contains instructions related to the importance for children with DS of having earlier access to diagnostic tests and antiviral management, especially in states of immune dysfunction, recurrent pulmonary infections, congenital heart disease and obesity. With regard to the RT-PCR test, it is suggested to perform the test on saliva spitted into a sterile bottle instead of on oropharyngeal mucosa brushing. Saliva testing is easy, safe, non-invasive and equally suitable (5) . A special recommendation to families is that of informing the primary care Doctors and/or the DS Center about suspicious symptoms in order to activate the paths synthesized in a dedicated flow chart (Fig.1) . A special alert is addressed to domestic accidents in order to avoid access to Hospital Emergency Departments or unnecessary hospitalization. The possible admission into an Intensive Care Unite (ICU) becomes a source of special concern. Furthermore, the Center, upon request, provides caregivers of children with DS with audio-visual consultation for any question or as a kind of preliminary triage, and stays at disposal of primary care doctors who have received a printed notice as a reminding. Effects of Pidotimod on recurrent respiratory infections in children with Down syndrome: a retrospective Italian study Why is COVID-19 so mild in children? Epidemiology and clinical features of COVID-19: A review of current literature Some drugs for COVID-19 A review of salivary diagnostics and its potential implication in detection of COVID-19 None.